Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/5/2025

Agoraphobia Treatment Guidelines

First-Line Treatments

  • The American Academy of Child and Adolescent Psychiatry recommends SSRIs (selective serotonin reuptake inhibitors) and cognitive-behavioral therapy (CBT), particularly exposure therapy, as first-line treatments for agoraphobia 1, 2, 3
  • SSRIs such as escitalopram, sertraline, paroxetine, and fluoxetine have demonstrated efficacy in treating panic disorder with agoraphobia 4

Medication Options

  • The Canadian Clinical Practice Guideline lists pregabalin as a first-line agent specifically for social anxiety disorder, not agoraphobia 5, 6, 7, 8, 9

Treatment Algorithm

  • The American Academy of Child and Adolescent Psychiatry suggests initiating SSRI therapy, such as escitalopram 10-20 mg/day or sertraline 50-200 mg/day, as first-line pharmacotherapy for agoraphobia 4

Critical Implementation Points

  • Starting SSRIs at subtherapeutic "test" doses is recommended, as initial adverse effects can include increased anxiety or agitation 4
  • Avoiding escitalopram doses exceeding 40 mg/day is advised due to QT prolongation risk 4

REFERENCES

4

Escitalopram versus Alprazolam for Anxiety Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025